UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012071
Receipt number R000013631
Scientific Title The combination therapy of HAIC and RT for tumor thrombosis.
Date of disclosure of the study information 2013/10/18
Last modified on 2019/03/20 14:30:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The combination therapy of HAIC and RT for tumor thrombosis.

Acronym

The combination therapy of HAIC and RT for tumor thrombosis.

Scientific Title

The combination therapy of HAIC and RT for tumor thrombosis.

Scientific Title:Acronym

The combination therapy of HAIC and RT for tumor thrombosis.

Region

Japan


Condition

Condition

Hepatocellular carcinoma

Classification by specialty

Medicine in general Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

prognosis

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Local tumor control rate

Key secondary outcomes

Overall survival rate


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

1) 20 Years and older.
2) Life expectancy of at least 12 weeks at the pre-treatment evaluation.
3) Advanced hepatocellular carcinoma with histological evidence on a biopsy specimen, or typical findings by dynamic CT or MRI.
4) Not suitable for resection or local ablation therapy or transcatheter arterial chemoembolization.
5) At least 4 weeks since last therapy for HCC.
6) Intrahepatic tumor which affects patient'prognosis.
7) Extrahepatic tumor apread which not affects patient's prognosis.
8) ECOG Performance status of 0 or 1.
9) Child-Pugh 5,6,7
10) Adequate bone marrow, liver and renal function, as assessed by the following laboratory requirements:
Granulocyte >= 3000/mm3
Platelet count >= 50,000 /mm3 Hemoglobin >= 8.5 g/dl
Total serum bilirubin <= 3 mg/dl
serum albimin>=2.8
Serum creatinine <= 1.5 mg/dl
prothrombin consumption test>=50%
Amylase <= 2 times upper limit of normal
11) Written Informed Consent must be obtained.

Key exclusion criteria

1) With other malignant disease.
2) A pregnant woman, or a woman suspected of pregnancy.
3) With severe infectious disease.
4) With history of severe allergy.
5) With severe renal function disease. 6) With severe allergy for 5FU or CDDP.
7) With severe bone marrow supression.
8) Esophageal and/or gastric varices which has high risk of bleeding and clinically significant gastro-
intestinal bleeding.
9) Serious hypertension
10) Any condition that is unstable or could jeopardize the safety of the patient and its compliance in the study, in the investigator's judgment.

Target sample size

70


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name kazuaki Chayama

Organization

Hiroshima university hospital

Division name

Departments of Gastroenterology and Metabolism

Zip code


Address

1-2-3 Kasumi, Minamiku, Hiroshima

TEL

082-257-5192

Email

Chayama@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Aikata

Organization

Hiroshima university hospital

Division name

Departments of Gastroenterology and Metabolismepartments of Gastroenterology and Metabolism

Zip code


Address

1-2-3 Kasumi, Minamiku, Hiroshima

TEL

082-257-5192

Homepage URL


Email

aikata@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima university hospital

Institute

Department

Personal name



Funding Source

Organization

Hiroshima university hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 10 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 09 Month 10 Day

Date of IRB

2013 Year 10 Month 07 Day

Anticipated trial start date

2013 Year 11 Month 01 Day

Last follow-up date

2016 Year 09 Month 30 Day

Date of closure to data entry

2017 Year 09 Month 30 Day

Date trial data considered complete

2017 Year 09 Month 30 Day

Date analysis concluded

2017 Year 09 Month 30 Day


Other

Other related information

We perform radiotherapy as additional treatment combined with HAIC for hepatocellular carcinoma tumor thrombosis. Further we examine the effectiveness and safety and follow up them after this treatment.


Management information

Registered date

2013 Year 10 Month 18 Day

Last modified on

2019 Year 03 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013631


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name